217 related articles for article (PubMed ID: 7847524)
1. Progesterone: a critical role in the pathogenesis of uterine myomas.
Rein MS; Barbieri RL; Friedman AJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):14-8. PubMed ID: 7847524
[TBL] [Abstract][Full Text] [Related]
2. Advances in uterine leiomyoma research: the progesterone hypothesis.
Rein MS
Environ Health Perspect; 2000 Oct; 108 Suppl 5():791-3. PubMed ID: 11035984
[TBL] [Abstract][Full Text] [Related]
3. Progestins and uterine leiomyoma.
Schweppe KW
Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():21-4. PubMed ID: 12227898
[TBL] [Abstract][Full Text] [Related]
4. Hormones and pathogenesis of uterine fibroids.
Reis FM; Bloise E; Ortiga-Carvalho TM
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():13-24. PubMed ID: 26725037
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the inhibitory effect of gonadotropin releasing hormone (GnRH) agonist, selective estrogen receptor modulator (SERM), antiprogesterone on myoma cell proliferation in vitro.
Chung YJ; Chae B; Kwak SH; Song JY; Lee AW; Jo HH; Lew YO; Kim JH; Kim MR
Int J Med Sci; 2014; 11(3):276-81. PubMed ID: 24516352
[TBL] [Abstract][Full Text] [Related]
6. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
7. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
[TBL] [Abstract][Full Text] [Related]
8. [Uterine leiomyoma: pathogenesis and treatment].
Fujii S
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Aug; 44(8):994-9. PubMed ID: 1402231
[TBL] [Abstract][Full Text] [Related]
9. Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells.
Hodges LC; Houston KD; Hunter DS; Fuchs-Young R; Zhang Z; Wineker RC; Walker CL
Mol Cell Endocrinol; 2002 Oct; 196(1-2):11-20. PubMed ID: 12385821
[TBL] [Abstract][Full Text] [Related]
10. Etiology, symptomatology, and diagnosis of uterine myomas.
Parker WH
Fertil Steril; 2007 Apr; 87(4):725-36. PubMed ID: 17430732
[TBL] [Abstract][Full Text] [Related]
11. The role of progesterone signaling in the pathogenesis of uterine leiomyoma.
Kim JJ; Sefton EC
Mol Cell Endocrinol; 2012 Jul; 358(2):223-31. PubMed ID: 21672608
[TBL] [Abstract][Full Text] [Related]
12. [Drug treatments for uterine fibroma: rationale].
Fernandez H; Azoulay C; Rostoker G;
J Gynecol Obstet Biol Reprod (Paris); 2005 Jun; 34(4):360-405. PubMed ID: 16136663
[No Abstract] [Full Text] [Related]
13. Growth factors and cytokines in uterine leiomyomas.
Andersen J
Semin Reprod Endocrinol; 1996 Aug; 14(3):269-82. PubMed ID: 8885057
[TBL] [Abstract][Full Text] [Related]
14. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
Takahashi K; Kawamura N; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
[TBL] [Abstract][Full Text] [Related]
15. Studies on leptin and leptin receptor gene expression in myometrium and uterine myomas of gnRH analogue-treated women.
Markowska A; Rucinski M; Drews K; Malendowicz LK
Eur J Gynaecol Oncol; 2006; 27(4):379-84. PubMed ID: 17009630
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyomas with T-cell infiltration associated with GnRH agonist goserelin.
Laforga JB; Aranda FI
Histopathology; 1999 May; 34(5):471-2. PubMed ID: 10231516
[No Abstract] [Full Text] [Related]
18. Current and future medical treatments for menometrorrhagia during the premenopause.
Bouchard P
Gynecol Endocrinol; 2011 Dec; 27 Suppl 1():1120-5. PubMed ID: 22182055
[TBL] [Abstract][Full Text] [Related]
19. Sex steroidal regulation of uterine leiomyoma growth and apoptosis.
Maruo T; Ohara N; Wang J; Matsuo H
Hum Reprod Update; 2004; 10(3):207-20. PubMed ID: 15140868
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
